Mc2 Therapeutics Limited
- Address
- 1a Guildford Business Park
Sponsor Overview
Specializations
Chronic Kidney Disease-associated Pruritus
Mc2 Therapeutics Limited is active in pruritus linked to chronic kidney disease, with clinical research centred on symptom relief in adults affected by persistent itching.
- CKD-associated itch
- Topical dermatologic therapy
- Symptom control in renal disease
The sponsor's research interest in this area focuses on treatment options for a burdensome cutaneous symptom in the setting of renal impairment.
Vulvar Lichen Sclerosus
The sponsor also studies vulvar lichen sclerosus, a chronic inflammatory condition affecting the vulvar tissue and associated with discomfort and skin changes.
- Inflammatory vulvar disorders
- Chronic dermatologic conditions
- Female genital skin disease
Clinical activity in this field reflects interest in therapies for long-term management of vulvar dermatoses.
Topical Dermatology
Across its trial portfolio, Mc2 Therapeutics Limited is focused on topical treatment for localized symptoms and skin inflammation.
- Topical cream formulations
- Local anti-inflammatory treatment
- Dermatologic symptom management
Its research activity is concentrated on skin-directed interventions for conditions requiring sustained external therapy.
Inflammatory and Pruritic Disorders
The sponsor's clinical interests extend to disorders defined by inflammation, itch, and chronic irritation, particularly where symptoms affect quality of life.
- Chronic itch syndromes
- Inflammatory skin disease
- Symptom-focused dermatology
This includes therapeutic areas where control of pruritic symptoms is a central clinical need.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A Parallel-group (2-Arm), Randomized, Double-blind, 12-week Trial to Evaluate the Efficacy and Safety of MC2-25 Cream and MC2-25 Vehicle in Subjects with Chronic Kidney Disease-associated Pruritus (CKD-aP) |  Germany Hungary Poland | Not Recruiting |
| A Study to Test How Well Alanyl Glutamine Cream Works and How Safe It Is for Adults with Itching Caused by Chronic Kidney Disease | Germany Hungary Poland | Not Yet Recruiting |
| Efficacy and Safety Evaluation of Topical Alanyl Glutamine (MC2-25) in Women with Vulvar Lichen Sclerosus: A Randomized, Double-Blind, Placebo-Controlled Trial |  Denmark | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 20 sites across their trial portfolio.
Therapeutic Focus
- 1.Skin and Connective Tissue Diseases3 trials247 other sponsors
Partnered Research Centres
20 centres- Address
- Szökefalvi Nagy Bela Utca 4/b, 6720 Szeged
- Address
- Langenbeckstrasse 1, Oberstadt, 55131 Mainz
- Address
- Ul. Mokra 4, 91-034 Lodz
- Address
- Ul. Ul. Sliczna 13, 50-566 Wroclaw
- Address
- Vasvari Pal u.38, 6500 Baja
- Address
- Rungsted Bytorv 1, 2960 Rungsted Kyst
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Mc2 Therapeutics Limited.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.